Certificate under regulation 74(5) of SEBI (Depositories Participants) Regulation 2018
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Asston Pharmaceuticals Ltd has submitted a certificate to BSE under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. This is a routine compliance filing where a listed company confirms, through its depository participant, that securities (shares) received for dematerialisation have been processed and credited to shareholders' demat accounts. No financial numbers, order details, or business figures are disclosed in this filing. The actual document content was not accessible from the link provided (BSE returned an error page), but the headline alone is sufficient to identify the nature of the submission. Such certificates are typically filed periodically as a regulatory housekeeping requirement.
This is a routine procedural filing with no material impact on the company's financials, operations, or share price. Shareholders need not take any action — it merely confirms that share dematerialisation requests are being processed normally.